Corrigendum to "Randomized controlled trial of daily teriparatide, weekly high-dose teriparatide, or bisphosphonate in patients with postmenopausal osteoporosis: The TERABIT study" [Bone 160 (2022) 116416]
1 Department of Orthopedic Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki University Hospital, Japan. Electronic address: kohchiba@estate.ocn.ne.jp.
2 Department of Orthopedic Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki University Hospital, Japan.
3 Watanabe Orthopedic Clinic, Nagasaki University Hospital, Japan.
4 Nagasaki Yurino Hospital, Nagasaki University Hospital, Japan.
5 Juko Memorial Nagasaki Hospital, Nagasaki University Hospital, Japan.
6 Furukawa Orthopedic Clinic, Nagasaki University Hospital, Japan.
7 Kondo Orthopedic Clinic, Nagasaki University Hospital, Japan.
8 Clinical Research Center, Nagasaki University Hospital, Japan.